Navigation Links
Childhood eye tumor made up of hybrid cells with jumbled development

A research team led by St. Jude Children's Research Hospital scientists has identified a potential new target for treatment of the childhood eye tumor retinoblastoma. Their work also settles a scientific debate by showing the cancer's cellular origins are as scrambled as the developmental pathways at work in the tumor.

Unlike other cancers that resemble a particular type of cell, researchers showed that retinoblastoma is a hybrid cell with elements of at least three different cell types. Investigators made the discovery using a variety of techniques to study 52 tumors donated by patients. The tumors were removed from a diverse group of patients, most treated at St. Jude and its international affiliates. The research appears in the August 16 edition of the scientific journal Cancer Cell.

Researchers also demonstrated that multiple, normally incompatible, developmental pathways are turned on simultaneously in retinoblastoma tumor cells. These pathways guide the fate of developing cells and determine what types of cells they become. This study found the tumor takes over at least one pathway to fuel its own growth, making it a promising drug development target.

The research provides additional insight into this rare tumor of the retina and is expected to advance understanding of retinoblastoma as well as aid development of more targeted therapies, said Michael Dyer, Ph.D., a member of the St. Jude Department of Developmental Neurobiology and the study's senior author. Justina McEvoy, Ph.D., and Jacqueline Flores-Otero, Ph.D., are co-first authors of the study and postdoctoral fellows in Dyer's laboratory.

Retinoblastoma is a tumor of the retina, which is the light-sensing membrane at the back of the eye. The tumor is found in about 5,000 individuals worldwide each year, mostly infants and toddlers. Although cure rates exceed 95 percent for patients whose cancer is contained in the eye, the prognosis is bleak if the tumor has spread.

For more than a century, scientists have tried to link the tumor's origins to one of the seven different types of cells that make up the retina. Although researchers have presented evidence to support various candidates, Dyer said the answer has remained elusive. Identifying where the tumor begins would likely speed efforts to develop new chemotherapy drugs. Increasingly, such agents are designed against particular molecular pathways active in cancer cells.

For this study, researchers took a comprehensive, unbiased approach to the search that included molecular, cellular and chemical analyses of tumor cells. Dyer and his colleagues reported that retinoblastoma tumors in both humans and mice include features from several different types of cells in the retina. The list includes cells called amacrine and horizontal interneurons, retinal progenitor cells and photoreceptors.

Investigators also screened individual cells from 192 retinoblastoma tumors to gauge the activity of about 20,000 human genes and nearly 19,000 mouse genes. The tumor cells came from the 52 patient in the study, mouse models of retinoblastoma and human tumors transplanted and growing in the eyes of mice. Scientists were surprised to find evidence in those cells that genes in multiple developmental pathways were functioning, including some pathways not normally expressed simultaneously.

Screening data are now available at no cost for use by other scientists at, "The finding that normal developmental programs are completely deregulated in this tumor is surprising and unexpected. It could also have therapeutic implications," Dyer said.

Researchers found retinoblastomas in both mice and humans have remarkably similar molecular profiles. Both involved very few genetic changes that distinguished normal cells from malignant cells. That result also sets the tumor apart from other cancers, which typically have a wider variety of genes switched on in tumor cells.

Scientists went on to show that blocking chemicals called monoamine neurotransmitters, which nerve cells normally use for communication, reduced growth in human retinoblastoma cells growing both in the laboratory and the eyes of mice. Dyer said the drugs used in this study, the anti-psychotic agents fluphenazine and chlorpromazine, better known as Thorazine, are unlikely to be used for treatment of retinoblastoma, but offer a starting point for future drug development.

The research also demonstrated that tumors transplanted directly from a patient into the same location in the eye of a mouse retained characteristics of the human tumor. The findings strengthen use of this approach for screening drugs for possible use against human cancers.


Contact: Summer Freeman
St. Jude Children's Research Hospital

Related biology news :

1. Research identifies genes vital to preventing childhood leukemia
2. Why childhood obesity? Its so much more than what kids eat
3. U of T researchers find link between childhood physical abuse, chronic fatigue syndrome
4. For puzzling childhood immune disorder, gene research opens door to first diagnostic test
5. Einstein researchers find key gene in childhood cancer
6. Researchers join forces to cure deadly childhood disease
7. Chemical in plastic linked to wheezing in childhood
8. Pediatricians confront the childhood obesity epidemic
9. Forsyth team gains new insight on childhood dental disease
10. Drug therapy shows significant benefit in treating a leading cause of childhood blindness
11. Scientists discover cell of origin for childhood muscle cancer
Post Your Comments:
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/29/2015)... , October 29, 2015 ... biometric authentication company focused on the growing mobile ... wallet announces that StackCommerce, a leading marketplace to ... featuring the Wocket® smart wallet on StackSocial for ... ) ("NXT-ID" or the "Company"), a biometric authentication ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ - ... the request of IIROC on behalf of the Toronto ... this news release there are no corporate developments that ... price. --> --> ... --> . --> Aeterna Zentaris ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
Breaking Biology Technology: